Alyeska Investment Group
ADPT icon

Alyeska Investment Group’s Adaptive Biotechnologies ADPT Stock Holding History

Alyeska Investment Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-500,000
Closed -$3.56M – 407
2022
Q3 		$3.56M Buy
+500,000
New +$4.71M 0.04% 285
2020
Q4 		– Sell
-367,983
Closed -$17.9M – 502
2020
Q3 		$17.9M Buy
+367,983
New +$15.5M 0.27% 117
2020
Q1 		– Sell
-529,803
Closed -$15.9M – 365
2019
Q4 		$15.9M Buy
529,803
+316,808
+149% +$9.1M 0.21% 146
2019
Q3 		$6.58M Sell
212,995
-37,502
-15% -$1.53M 0.1% 197
2019
Q2 		$12.1M Buy
+250,497
New +$11.1M 0.16% 155

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's ADPT Position: Q4 2022 in Review

Alyeska Investment Group sold out of Adaptive Biotechnologies (ADPT) in Q4 2022, closing a stake of 500,000 shares — an estimated $3.56M sold.

Alyeska Investment Group first reported a position in ADPT in Q2 2019 and held it in 5 quarters. The position peaked at $17.9M in Q3 2020. 223 funds tracked by Wall St. Rank hold ADPT as of Q4 2022.

  • Alyeska Investment Group reported no remaining Adaptive Biotechnologies position as of Q4 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 500,000 Adaptive Biotechnologies shares in Q4 2022, an estimated $3.56M.
  • Alyeska Investment Group first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 5 quarters.
  • Alyeska Investment Group's Adaptive Biotechnologies position peaked at $17.9M in Q3 2020.
  • 223 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.